Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.59 |
| ▸ | GAA | P10253 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MPO | P05164 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | CFTR | P13569 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.53 |
| ▸ | MMP3 | P08254 | 1/20 | 0.53 |
| ▸ | FADS1 | O60427 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29463616 | 1.00 | KDM4E (0.59) | KDM4EGAASMN1; SMN2MPOHIF1A | |
| Iodobenzene SCHEMBL27496777 | 0.89 | KDM4E (0.49) | KDM4EGAASMN1; SMN2MPOHIF1A | |
| SCHEMBL9921278 | 0.84 | KDM4E (0.60) | KDM4EGAASMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL1331243 | 0.83 | GAA (0.73) | KDM4EGAASMN1; SMN2MPOHIF1A | |
| SCHEMBL11293418 | 0.83 | KDM4E (0.50) | KDM4EGAASMN1; SMN2MPOHIF1A | |
| SCHEMBL112991 | 0.82 | ALDH1A1 (0.55) | KDM4EGAAALDH1A1HSD17B10CFTR | |
| SCHEMBL27859247 | 0.81 | MMP2 (0.62) | KDM4EGAASMN1; SMN2MPOHIF1A | |
| SCHEMBL5245919 | 0.81 | HDAC1 (0.61) | KDM4EGAASMN1; SMN2MPOHIF1A | |
| SCHEMBL16677840 | 0.80 | ALDH1A1 (0.53) | KDM4EGAASMN1; SMN2ALDH1A1HSD17B10 | |
| SCHEMBL8302862 | 0.80 | ALDH1A1 (0.53) | KDM4EGAASMN1; SMN2ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119176819-B | Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase | 山东第二医科大学 | 2025-02-14 | — | — | CN | claimed |
| CN-119176819-A | Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase | 山东第二医科大学 | 2024-12-24 | — | — | CN | claimed |
| US-20240319601-A1 | METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2024-09-26 | — | — | US | claimed |
| CN-117597628-A | Method for forming pattern | 三星SDI株式会社 | 2024-02-23 | — | — | CN | claimed |
| US-20240019784-A1 | METAL CONTAINING PHOTORESIST DEVELOPER COMPOSITION, AND METHOD OF FORMING PATTERNS INCLUDING STEP OF DEVELOPING USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2024-01-18 | — | — | US | claimed |
| CN-117348341-A | Metal-containing photoresist developer composition and pattern forming method | 三星SDI株式会社 | 2024-01-05 | — | — | CN | claimed |
| CN-115703845-A | Oligosaccharide linker and side chain hydrophilic fragment combined sugar chain site-directed antibody-drug conjugate, preparation method and application thereof | 中国科学院上海药物研究所 | 2023-02-17 | — | — | CN | claimed |
| WO-2023003215-A1 | METHOD OF FORMING PATTERNS | 삼성에스디아이 주식회사 | 2023-01-26 | — | — | WO | claimed |
| CN-113416989-B | Silver plating process and silver plated part | 苏州瑞港环保科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-113416989-A | Silver plating process and silver plated part | 苏州瑞港环保科技有限公司 | 2021-09-21 | — | — | CN | claimed |
| EP-1461010-A2 | HYDROXAMIC ACID AND ITS DERIVATIVES AS INHIBITORS OF MELANOCYTE TYROSINASE FOR TOPICAL SKIN LIGHTENERS | Integriderm, Inc. (US) | 2004-09-29 | — | — | EP | claimed |
| US-20030199558-A1 | Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners | INTEGRIDERM, INC. | 2003-10-23 | — | — | US | claimed |
| WO-2003057184-A2 | HYDROXAMIC ACID AND ITS DERIVATIVES AS INHIBITORS OF MELANOCYTE TYROSINASE FOR TOPICAL SKIN LIGHTENERS | INTEGRIDERM, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| WO-1992016200-A1 | THE USE OF HYDROXAMIC ACID DERIVATIVES TO INHIBIT VIRAL REPLICATION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1992-10-01 | — | — | WO | claimed |
| CN-119176819-B | Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase | 山东第二医科大学 | 2025-02-14 | — | — | CN | disclosed |
| CN-119176819-A | Method for preparing 3, 6-dihydro-1, 2-oxazine derivative by iodine catalysis in aqueous phase | 山东第二医科大学 | 2024-12-24 | — | — | CN | disclosed |
| US-20240319601-A1 | METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2024-09-26 | — | — | US | disclosed |
| EP-0073912-A1 | Oxo-quinazoline-(thiono)-phosphoric(phosphonic)-acid esters or amides, process for their preparation and their use as pesticides | BAYER AG (DE) | 1983-03-16 | — | — | EP | disclosed |
| US-4359476-A | Adjacently substituted cycloalkane-amide analgesics | THE UPJOHN COMPANY (US) | 1982-11-16 | — | — | US | disclosed |
| US-3978208-A | ACETOHYDROXAMIC ACID | EISAI CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199558-A1 | Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners | TYR, MC1R, MITF | KDM4E 2107/4885GAA 22/4885SMN1; SMN2 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.